Evidence map›Paper›PMID 29876206›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2018

Integrated Microfluidic Device for Drug Studies of Early

Li Dong, Radek Jankele, Matteo Cornaglia, Thomas Lehnert, Pierre Gönczy, Martin A M Gijs

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Nanoplasmonic Single-Tumoroid Microarray for Real-Time Secretion Analysis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Automated phenotyping ofMicrosystems & nanoengineering · 2020
    Article
  7. Article
  8. Review
  9. Integrated Microfluidic Device for Drug Studies of EarlyAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Li DongLaboratory of Microsystems Ecole Polytechnique Fédérale de Lausanne (EPFL) Lausanne 1015 Switzerland.ORCID 0000-0002-3034-888X
Radek JankeleSwiss Institute for Experimental Cancer Research (ISREC) School of Life Sciences Ecole Polytechnique Fédérale de Lausanne (EPFL) Lausanne 1015 Switzerland.
Matteo CornagliaLaboratory of Microsystems Ecole Polytechnique Fédérale de Lausanne (EPFL) Lausanne 1015 Switzerland.
Thomas LehnertLaboratory of Microsystems Ecole Polytechnique Fédérale de Lausanne (EPFL) Lausanne 1015 Switzerland.
Pierre GönczySwiss Institute for Experimental Cancer Research (ISREC) School of Life Sciences Ecole Polytechnique Fédérale de Lausanne (EPFL) Lausanne 1015 Switzerland.ORCID 0000-0002-6305-6883
Martin A M GijsLaboratory of Microsystems Ecole Polytechnique Fédérale de Lausanne (EPFL) Lausanne 1015 Switzerland.ORCID 0000-0002-8735-9547
École Polytechnique Fédérale de Lausanne · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Small molecules inhibitors are powerful tools for studying multiple aspects of cell biology and stand at the forefront of drug discovery pipelines. However, in the early

Indexed as

C. elegansdrug studiesembryogenesismicrofluidic devices

Identifiers

PMID29876206
PMCPMC5980161
OpenAlexW2790963077

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.